ID
int64 1
9.11k
| age
float64 18
102
| death
int64 0
1
| sex
stringclasses 2
values | hospdead
int64 0
1
| slos
int64 3
343
| d.time
int64 3
2.03k
| dzgroup
stringclasses 8
values | dzclass
stringclasses 4
values | num.co
int64 0
9
| edu
float64 0
31
⌀ | income
stringclasses 4
values | scoma
float64 0
100
⌀ | charges
float64 1.17k
1.44M
⌀ | totcst
float64 0
633k
⌀ | totmcst
float64 -102.72
711k
⌀ | avtisst
float64 1
83
⌀ | race
stringclasses 5
values | sps
float64 0.2
99.2
⌀ | aps
float64 0
143
⌀ | surv2m
float64 0
0.97
⌀ | surv6m
float64 0
0.95
⌀ | hday
int64 1
148
| diabetes
int64 0
1
| dementia
int64 0
1
| ca
stringclasses 3
values | prg2m
float64 0
1
⌀ | prg6m
float64 0
1
⌀ | dnr
stringclasses 3
values | dnrday
float64 -88
285
⌀ | meanbp
float64 0
195
⌀ | wblc
float64 0
200
⌀ | hrt
float64 0
300
⌀ | resp
float64 0
90
⌀ | temp
float64 31.7
41.7
⌀ | pafi
float64 12
890
⌀ | alb
float64 0.4
29
⌀ | bili
float64 0.1
63
⌀ | crea
float64 0.1
21.5
⌀ | sod
float64 110
181
⌀ | ph
float64 6.83
7.77
⌀ | glucose
float64 0
1.09k
⌀ | bun
float64 1
300
⌀ | urine
float64 0
9k
⌀ | adlp
float64 0
7
⌀ | adls
float64 0
7
⌀ | sfdm2
stringclasses 5
values | adlsc
float64 0
7.07
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5,101 | 78.89697 | 0 |
female
| 0 | 9 | 670 |
CHF
|
COPD/CHF/Cirrhosis
| 2 | 11 |
under $11k
| 0 | 21,818 | 12,756.3516 | 13,824 | 13 |
white
| 15.599609 | 16 | 0.86792 | 0.781982 | 1 | 0 | 0 |
no
| null | null |
no dnr
| 9 | 66 | 7 | 110 | 32 | 36.69531 | 226.0625 | 3.199707 | null | 0.5 | 138 | 7.379883 | 260 | 8 | 4,525 | 0 | 0 |
no(M2 and SIP pres)
| 0 |
5,102 | 40.80798 | 1 |
male
| 1 | 7 | 7 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 12 |
under $11k
| 0 | 60,445 | 34,727.7812 | 36,611 | 53 |
white
| 26.699219 | 44 | 0.834961 | 0.777954 | 2 | 0 | 0 |
no
| null | null |
no dnr
| 7 | 122 | 9.798828 | 55 | 14 | 39.5 | 151.40625 | 3 | 1.199951 | 0.799927 | 140 | 7.5 | 291 | 13 | 2,505 | null | 0 |
<2 mo. follow-up
| 0 |
5,103 | 72.02997 | 1 |
male
| 1 | 28 | 28 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 3 |
under $11k
| 0 | 109,406 | 66,974.1875 | 64,869 | 40.75 |
black
| 39.59375 | 86 | 0.417969 | 0.29895 | 1 | 0 | 0 |
no
| 0.5 | 0.4 |
dnr after sadm
| 28 | 63 | 11 | 74 | 42 | 38.59375 | 374.9375 | 2.5 | 0.299988 | 4.699219 | 145 | 7.40918 | 87 | 113 | 847 | null | 0 |
<2 mo. follow-up
| 0 |
5,104 | 60.90298 | 1 |
male
| 0 | 76 | 253 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 8 |
$11-$25k
| 0 | 275,754 | 160,613.25 | 191,746 | 42 |
white
| 29.597656 | 48 | 0.623901 | 0.519897 | 4 | 0 | 0 |
yes
| null | null |
no dnr
| 76 | 103 | 10.099609 | 55 | 10 | 35.39844 | null | null | 0.899902 | 0.799927 | 136 | null | 152 | 14 | null | null | 0 | null | 0 |
5,105 | 46.38998 | 0 |
female
| 0 | 19 | 667 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | null |
under $11k
| 41 | 60,434 | 35,845.125 | 34,689 | 31 |
black
| 28.097656 | 46 | 0.687988 | 0.595947 | 1 | 1 | 0 |
no
| 0.8 | 0.7 |
no dnr
| 19 | 108 | 8.699219 | 110 | 36 | 36.19531 | 55 | null | 11 | 1.199951 | 148 | 7.479492 | 93 | 31 | 6,590 | null | 6 |
SIP>=30
| 6 |
5,106 | 75.034 | 0 |
female
| 0 | 16 | 668 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 7 |
under $11k
| 0 | 33,122 | 21,182.2344 | 22,587 | 15.666664 |
white
| 21.898438 | 39 | 0.803955 | 0.738892 | 1 | 0 | 0 |
no
| 0.85 | 0.75 |
no dnr
| 16 | 62 | 5.199219 | 130 | 52 | 32.09375 | 144 | 2.699707 | 5.899414 | 1.699951 | 137 | 7.369141 | 42 | 74 | 1,145 | null | 1 |
no(M2 and SIP pres)
| 1 |
5,107 | 63.17297 | 1 |
female
| 0 | 6 | 375 |
Colon Cancer
|
Cancer
| 1 | 16 |
>$50k
| 0 | 10,983 | 6,165.0703 | 4,119 | 16 |
white
| 7.199219 | 9 | 0.914917 | 0.80188 | 1 | 0 | 0 |
metastatic
| 0.8 | 0.6 |
no dnr
| 6 | 105 | 19.398438 | 75 | 28 | 36 | 170 | null | 0.799927 | 1.399902 | 148 | 7.40918 | 283 | 64 | 1,470 | 0 | null |
no(M2 and SIP pres)
| 0.494751 |
5,108 | 65.89697 | 1 |
female
| 1 | 5 | 5 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3 | 7 |
under $11k
| 9 | 58,303 | 34,019 | 31,352 | 33 |
white
| 34.09375 | 68 | 0.472961 | 0.353943 | 10 | 1 | 0 |
no
| 0.2 | 0.2 |
dnr after sadm
| 5 | 107 | 5.199219 | 108 | 20 | 36.5 | 257.125 | 3.799805 | 0.5 | 1.199951 | 128 | 7.469727 | 105 | 33 | 1,025 | null | 6 |
<2 mo. follow-up
| 6 |
5,109 | 74.81494 | 1 |
male
| 0 | 6 | 347 |
Colon Cancer
|
Cancer
| 1 | 8 |
under $11k
| 0 | 8,861 | 4,987.0117 | 3,160 | 12 |
white
| 13.5 | 9 | 0.843994 | 0.656982 | 1 | 0 | 0 |
metastatic
| 0.8 | 0.5 |
no dnr
| 6 | 73 | 4.799805 | 75 | 20 | 36.29688 | 257.125 | 3.399902 | 0.399963 | 1.099854 | 138 | 7.429688 | 99 | 13 | 2,225 | 0 | 0 |
no(M2 and SIP pres)
| 0 |
5,110 | 60.41599 | 0 |
female
| 0 | 37 | 665 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 12 |
$11-$25k
| 9 | 105,918 | 66,441.9375 | 62,850 | 29 |
white
| 27.796875 | 32 | 0.737915 | 0.655884 | 1 | 0 | 0 |
no
| 0.6 | 0.6 |
no dnr
| 37 | 127 | 15.099609 | 125 | 32 | 38.39844 | 204.0625 | null | null | 1.299805 | 145 | 7.459961 | 191 | 19 | 900 | null | 7 |
no(M2 and SIP pres)
| 7 |
5,111 | 55.84399 | 0 |
male
| 0 | 27 | 665 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 5 |
under $11k
| 9 | 40,892 | 27,040.8281 | 25,830 | 12.5 |
black
| 19.097656 | 46 | 0.862915 | 0.814941 | 2 | 0 | 0 |
no
| 0.8 | 0.7 |
no dnr
| 27 | 100 | 8.398438 | 72 | 32 | 38.39844 | 292 | 3.299805 | 0.399963 | 0.899902 | 133 | 7.469727 | 93 | 23 | null | 0 | null | null | 0.494751 |
5,112 | 43.05798 | 1 |
male
| 0 | 4 | 250 |
Lung Cancer
|
Cancer
| 1 | 12 |
$25-$50k
| 0 | 9,909 | 5,033.582 | 3,959 | 12 |
white
| 20.398438 | 14 | 0.692993 | 0.401978 | 1 | 0 | 0 |
metastatic
| 0.8 | 0.6 |
no dnr
| 4 | 105 | 11.898438 | 55 | 12 | 36.79688 | 118.45312 | 3.199707 | 0.599976 | 0.899902 | 142 | 7.449219 | 133 | 30 | 3,840 | 0 | 0 |
no(M2 and SIP pres)
| 0 |
5,113 | 55.26099 | 1 |
male
| 1 | 7 | 7 |
MOSF w/Malig
|
ARF/MOSF
| 1 | 12 |
$11-$25k
| 0 | 24,646 | 14,752.6719 | 12,783 | 21.5 |
white
| 22.296875 | 38 | 0.684937 | 0.591919 | 1 | 0 | 0 |
metastatic
| 0.2 | 0.1 |
dnr after sadm
| 6 | 58 | 18.796875 | 55 | 24 | 38.29688 | 169.375 | 1.599854 | 0.399963 | 1 | 131 | 7.369141 | 177 | 21 | 1,520 | null | 6 |
<2 mo. follow-up
| 6 |
5,114 | 57.06998 | 1 |
male
| 1 | 35 | 35 |
MOSF w/Malig
|
ARF/MOSF
| 1 | 14 |
>$50k
| 41 | 157,909 | 92,457.75 | 87,630 | 43.75 |
white
| 33.796875 | 56 | 0.089996 | 0.035995 | 14 | 0 | 0 |
metastatic
| 0.4 | 0.2 |
dnr after sadm
| 16 | 70 | 14.599609 | 96 | 22 | 35.59375 | 252.15625 | null | null | 0.799927 | 125 | 7.419922 | 209 | 11 | 2,100 | null | 0 |
<2 mo. follow-up
| 0 |
5,115 | 60.32898 | 0 |
male
| 0 | 15 | 663 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 24 | null | 0 | 49,023 | 29,819.8281 | 30,906 | 29.666656 |
white
| 35.296875 | 41 | 0.612915 | 0.506958 | 1 | 0 | 0 |
no
| null | null |
no dnr
| 15 | 113 | 3.699707 | 100 | 12 | 36.59375 | null | 2.899902 | null | 0.899902 | 134 | null | 209 | 9 | 2,970 | null | 0 |
no(M2 and SIP pres)
| 0 |
5,116 | 75.32098 | 1 |
female
| 1 | 19 | 19 |
Coma
|
Coma
| 2 | null |
under $11k
| 41 | 71,949 | null | null | 33.666657 |
black
| 21 | 30 | 0.490967 | 0.418945 | 1 | 0 | 0 |
no
| 0.8 | 0.75 |
dnr after sadm
| 12 | 113 | 7 | 80 | 20 | 38.19531 | null | 2.799805 | 1.199951 | 1.199951 | 134 | null | 117 | 28 | 900 | null | 2 |
<2 mo. follow-up
| 2 |
5,117 | 66.935 | 1 |
male
| 0 | 38 | 200 |
MOSF w/Malig
|
ARF/MOSF
| 1 | null | null | 9 | 70,401 | 42,746.9688 | 42,579 | 17.25 |
white
| 26.796875 | 54 | 0.415955 | 0.296997 | 10 | 0 | 0 |
metastatic
| 0.5 | 0.3 |
dnr after sadm
| 12 | 77 | 3.599609 | 75 | 24 | 35.59375 | 360 | 3.199707 | 2.199707 | 3.799805 | 135 | 7.369141 | 161 | 101 | 780 | null | null | null | 3.121582 |
5,118 | 53.577 | 0 |
female
| 0 | 58 | 661 |
Coma
|
Coma
| 4 | 12 | null | 37 | 123,391 | 72,837.125 | 80,034 | 26 |
black
| 21.398438 | 26 | 0.599976 | 0.535889 | 14 | 1 | 0 |
no
| 0.6 | 0.5 |
no dnr
| 58 | 118 | 12.699219 | 125 | 24 | 36.89844 | 203.3125 | null | 0.5 | 0.599976 | 138 | 7.459961 | 203 | 37 | 2,535 | null | 4 |
adl>=4 (>=5 if sur)
| 4 |
5,119 | 64.86798 | 1 |
male
| 0 | 4 | 140 |
COPD
|
COPD/CHF/Cirrhosis
| 3 | 12 |
$11-$25k
| 0 | 8,329 | 5,168.0312 | 4,771 | 7 |
white
| 16 | 17 | 0.875 | 0.792969 | 1 | 1 | 0 |
yes
| null | null |
no dnr
| 4 | 75 | 24.5 | 80 | 24 | 38 | 293.3125 | 2.5 | 0.799927 | 1.699951 | 133 | 7.379883 | 10 | 192 | null | null | 0 |
no(M2 and SIP pres)
| 0 |
5,120 | 78.54596 | 1 |
female
| 1 | 7 | 7 |
Coma
|
Coma
| 2 | 8 |
under $11k
| 61 | 32,912 | null | null | 26.5 |
black
| 40.59375 | 63 | 0 | 0 | 12 | 1 | 0 |
yes
| 0.01 | 0 |
dnr after sadm
| 5 | 118 | 19 | 125 | 46 | 38.79688 | 240 | null | 1.199951 | 0.5 | 143 | 7.429688 | 212 | 3 | 4,445 | null | 6 |
<2 mo. follow-up
| 6 |
5,121 | 66.57098 | 1 |
male
| 1 | 6 | 6 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 12 |
under $11k
| 100 | 61,060 | 35,093.3125 | 36,950 | 41 |
white
| 28 | 61 | 0.201996 | 0.108994 | 6 | 1 | 0 |
no
| 0 | 0 |
dnr after sadm
| 4 | 103 | 7.399414 | 85 | 22 | 36.89844 | null | null | 0.399963 | 1.299805 | 140 | null | 95 | 24 | null | null | null |
<2 mo. follow-up
| 3.190918 |
5,122 | 49.52798 | 0 |
female
| 0 | 11 | 659 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 16 |
under $11k
| 0 | 66,030 | 37,520.5625 | 38,252 | 32 |
white
| 23.5 | 27 | 0.829956 | 0.771973 | 5 | 0 | 0 |
no
| 0.9 | 0.6 |
no dnr
| 11 | 78 | 12.699219 | 115 | 42 | 38.69531 | 236.65625 | 3 | 3.899902 | 3.299805 | 148 | 7.419922 | 174 | 96 | 1,000 | null | 0 |
no(M2 and SIP pres)
| 0 |
5,123 | 70.32196 | 1 |
male
| 0 | 15 | 467 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3 | 4 |
under $11k
| 0 | 53,749 | 29,518.1562 | 27,179 | 29.666656 |
white
| 53 | 78 | 0.017998 | 0.004 | 6 | 1 | 0 |
yes
| 0.5 | 0.2 |
no dnr
| 15 | 30 | 7.799805 | 135 | 33 | 40.59375 | 305 | null | null | 5.799805 | 144 | 7.319336 | 90 | 54 | 140 | null | 0 |
no(M2 and SIP pres)
| 0 |
5,124 | 34.168 | 1 |
female
| 1 | 41 | 41 |
Coma
|
Coma
| 1 | 11 |
under $11k
| 44 | 63,687 | 39,086.125 | 42,579 | 23.5 |
black
| 14.5 | 16 | 0.855957 | 0.826904 | 3 | 0 | 0 |
no
| null | null |
dnr after sadm
| 34 | 100 | 11.599609 | 120 | 28 | 36.59375 | null | 2.699707 | 0.5 | 0.599976 | 141 | null | 61 | 17 | null | null | 0 |
<2 mo. follow-up
| 0 |
5,125 | 63.66599 | 1 |
male
| 0 | 32 | 415 |
Coma
|
Coma
| 1 | 14 | null | 44 | 56,792 | 36,616.5 | 39,677 | 20.25 |
black
| 19.796875 | 38 | 0.61792 | 0.554932 | 1 | 1 | 0 |
no
| 0.3 | 0.3 |
no dnr
| 32 | 38 | 71.890625 | 145 | 12 | 38.69531 | 104.28125 | 1.599854 | 0.299988 | 2.5 | 145 | 7.379883 | 85 | 28 | 1,110 | null | 0 |
adl>=4 (>=5 if sur)
| 0 |
5,126 | 59.29099 | 0 |
male
| 0 | 6 | 659 |
COPD
|
COPD/CHF/Cirrhosis
| 1 | 11 |
under $11k
| 0 | 4,828 | 3,260.1367 | 3,606 | 8 |
black
| 17.296875 | 24 | 0.907959 | 0.845947 | 1 | 0 | 0 |
no
| 0.9 | 0.8 |
no dnr
| 6 | 132 | 11.298828 | 155 | 10 | 36.29688 | 147.5 | 1.5 | 3.799805 | 2.399902 | 133 | 7.359375 | 60 | 31 | 1,120 | 0 | null |
no(M2 and SIP pres)
| 0.494751 |
5,127 | 62.29199 | 0 |
female
| 0 | 9 | 658 |
CHF
|
COPD/CHF/Cirrhosis
| 3 | 5 | null | 0 | 8,323 | 6,026.5977 | 6,719 | 15.5 |
black
| 15.5 | 40 | 0.907959 | 0.843994 | 1 | 1 | 0 |
no
| null | null |
no dnr
| 9 | 112 | 18.699219 | 95 | 26 | 38.39844 | 106.65625 | null | null | 3.099609 | 152 | 7.349609 | 362 | 86 | 1,790 | 1 | 4 |
no(M2 and SIP pres)
| 4 |
5,128 | 68.08197 | 1 |
female
| 1 | 8 | 8 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3 | null |
under $11k
| 61 | 57,265 | 32,837.0625 | 35,035 | 35.5 |
black
| 28.5 | 58 | 0.257996 | 0.152985 | 12 | 0 | 0 |
yes
| 0.3 | 0.25 |
dnr before sadm
| -2 | 55 | 11.199219 | 75 | 40 | 36 | 189.78125 | 2.299805 | null | 1.5 | 135 | 7.489258 | 88 | 22 | 695 | null | 0 |
<2 mo. follow-up
| 0 |
5,129 | 73.71399 | 1 |
male
| 1 | 7 | 7 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 12 |
$11-$25k
| 0 | 80,540 | 43,399.2812 | 47,371 | 46 |
white
| 35.296875 | 60 | 0.398987 | 0.279968 | 3 | 0 | 0 |
yes
| 0.1 | 0 |
no dnr
| 7 | 69 | 5.599609 | 76 | 14 | 35.59375 | null | 2.899902 | 0.5 | 0.599976 | 133 | null | 90 | 4 | null | null | 5 |
<2 mo. follow-up
| 5 |
5,130 | 48.25497 | 1 |
male
| 0 | 13 | 395 |
Colon Cancer
|
Cancer
| 1 | 16 | null | 0 | 23,651 | 13,812.6797 | 12,455 | 11.5 |
white
| 29.398438 | 19 | 0.631958 | 0.320984 | 1 | 0 | 0 |
metastatic
| 0.7 | 0.3 |
no dnr
| 13 | 48 | 8.298828 | 65 | 8 | 37.89844 | 247.5 | 2.399902 | null | 1.599854 | 138 | 7.459961 | 165 | 70 | 97.5 | 1 | 6 |
no(M2 and SIP pres)
| 6 |
5,131 | 37.20697 | 1 |
male
| 1 | 15 | 15 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3 | 9 | null | 41 | 111,985 | null | null | 43 |
black
| 24.199219 | 31 | 0.780884 | 0.709961 | 2 | 0 | 0 |
no
| 0.5 | 0.3 |
dnr after sadm
| 15 | 74 | 7.899414 | 74 | 20 | 37.69531 | null | null | null | 0.599976 | 134 | null | 80 | 4 | null | null | 1 |
<2 mo. follow-up
| 1 |
5,132 | 83.29895 | 1 |
female
| 0 | 24 | 146 |
CHF
|
COPD/CHF/Cirrhosis
| 2 | 8 |
under $11k
| 9 | 15,835 | 12,287.8438 | 12,138 | 5.666664 |
black
| 15.898438 | 23 | 0.833984 | 0.727905 | 1 | 0 | 1 |
no
| 0.8 | 0.6 |
no dnr
| 24 | 45 | 2.899902 | 125 | 26 | 38.09375 | 80 | 4.099609 | 25.296875 | 5.699219 | 146 | 7.239258 | 55 | 60 | 5 | null | 1 |
no(M2 and SIP pres)
| 1 |
5,133 | 70.95099 | 1 |
male
| 1 | 37 | 37 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 12 | null | 44 | 76,564 | 45,860.5312 | 47,719 | 29.25 |
white
| 29.898438 | 52 | 0.480957 | 0.362976 | 1 | 0 | 0 |
no
| 0.2 | 0.5 |
dnr after sadm
| 13 | 62 | 10.099609 | 195 | 12 | 38.39844 | 131.09375 | 1.5 | 1.899902 | 2 | 138 | 7.379883 | 112 | 54 | 1,217 | null | 0 |
<2 mo. follow-up
| 0 |
5,134 | 79.78595 | 1 |
female
| 1 | 8 | 8 |
CHF
|
COPD/CHF/Cirrhosis
| 4 | 10 | null | 0 | 6,594 | 4,640.9648 | 5,491 | 24.5 |
white
| 20.296875 | 37 | 0.80896 | 0.690918 | 1 | 1 | 0 |
no
| null | null |
no dnr
| 8 | 115 | 13.099609 | 105 | 32 | 38.29688 | 284 | null | null | 0.699951 | 138 | 7.449219 | 94 | 6 | 3,020 | 0 | 0 |
<2 mo. follow-up
| 0 |
5,135 | 55.59998 | 0 |
male
| 0 | 11 | 655 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 10 |
under $11k
| 9 | 36,284 | null | null | 26 |
white
| 14.798828 | 12 | 0.907959 | 0.875 | 1 | 0 | 0 |
no
| 0.75 | 0.6 |
no dnr
| 11 | 128 | 14.099609 | 75 | 12 | 37.69531 | 188.5625 | 3 | 0.599976 | 0.599976 | 143 | 7.419922 | 181 | 22 | 2,640 | 0 | 0 |
adl>=4 (>=5 if sur)
| 0 |
5,136 | 39.23099 | 0 |
female
| 0 | 37 | 655 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 12 |
$11-$25k
| 9 | 159,687 | 95,423.4375 | 87,275 | 43 |
white
| 33.09375 | 88 | 0.73291 | 0.650879 | 1 | 0 | 0 |
no
| null | null |
no dnr
| 37 | 130 | 15.699219 | 55 | 40 | 37.5 | 371.375 | null | null | 1.5 | 137 | 7.429688 | 156 | 36 | 1,225 | null | 0 |
no(M2 and SIP pres)
| 0 |
5,137 | 35.32098 | 1 |
male
| 1 | 25 | 25 |
Coma
|
Coma
| 0 | 14 |
under $11k
| 55 | 192,755 | null | null | 34 |
black
| 23.699219 | 30 | 0.60498 | 0.540894 | 34 | 0 | 0 |
no
| 0.1 | 0 |
no dnr
| 25 | 153 | 13 | 110 | 24 | 35.09375 | 140.8125 | 3.899902 | null | 1.299805 | 136 | 7.40918 | 205 | 49 | 4,230 | null | 0 |
<2 mo. follow-up
| 0 |
5,138 | 66.81494 | 1 |
female
| 1 | 20 | 20 |
MOSF w/Malig
|
ARF/MOSF
| 1 | 14 | null | 0 | 65,242 | 38,550.9375 | 37,962 | 24 |
white
| 27.097656 | 58 | 0.540894 | 0.425964 | 9 | 0 | 0 |
yes
| 0.5 | 0.5 |
dnr after sadm
| 16 | 105 | 8.199219 | 65 | 14 | 35.09375 | 385.6875 | null | 0.399963 | 1.899902 | 139 | 7.489258 | 231 | 52 | 1,950 | null | 3 |
<2 mo. follow-up
| 3 |
5,139 | 58.85797 | 1 |
male
| 0 | 21 | 90 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 12 |
under $11k
| 9 | 47,752 | 30,081.6094 | 32,939 | 14.333328 |
black
| 24.398438 | 36 | 0.747925 | 0.668945 | 8 | 1 | 0 |
no
| 0.7 | 0.7 |
no dnr
| 21 | 142 | 14.599609 | 135 | 10 | 38.69531 | 388 | null | 0.599976 | 0.699951 | 146 | 7.429688 | 108 | 5 | 3,100 | null | 7 |
adl>=4 (>=5 if sur)
| 7 |
5,140 | 47.65799 | 0 |
male
| 0 | 12 | 652 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 8 |
$11-$25k
| 0 | 26,875 | 15,939.4609 | 16,254 | 16 |
black
| 28.597656 | 59 | 0.785889 | 0.715942 | 2 | 0 | 0 |
no
| 0.95 | 0.95 |
no dnr
| 12 | 118 | 5.199219 | 65 | 6 | 36.5 | 396 | 3.199707 | 0.5 | 0.699951 | 139 | 7.509766 | 132 | null | 2,675 | 0 | 0 |
no(M2 and SIP pres)
| 0 |
5,141 | 68.87897 | 0 |
male
| 0 | 21 | 652 |
CHF
|
COPD/CHF/Cirrhosis
| 3 | 12 |
$11-$25k
| 0 | 15,410 | 11,309.7656 | 11,194 | 6 |
white
| 16.097656 | 12 | 0.887939 | 0.813965 | 1 | 1 | 0 |
no
| null | null |
no dnr
| 21 | 72 | 6.099609 | 105 | 14 | 36.19531 | 290 | null | 1.099854 | 1.199951 | 135 | 7.449219 | 117 | 20 | 5,460 | null | 0 |
adl>=4 (>=5 if sur)
| 0 |
5,142 | 71.92096 | 0 |
female
| 0 | 26 | 652 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 12 |
under $11k
| 9 | 99,233 | 57,108.9688 | 59,108 | 34.5 |
white
| 21.398438 | 45 | 0.782959 | 0.712891 | 2 | 0 | 0 |
no
| 0.5 | 0.4 |
no dnr
| 26 | 52 | 24 | 115 | 18 | 37.89844 | 98.32812 | 2 | null | 0.799927 | 133 | 7.399414 | 129 | 34 | 1,290 | null | 0 |
no(M2 and SIP pres)
| 0 |
5,143 | 77.18799 | 1 |
male
| 0 | 32 | 90 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 12 |
under $11k
| 9 | 50,610 | 31,015.6094 | 32,517 | 19.75 |
black
| 19.699219 | 15 | 0.789917 | 0.721924 | 2 | 0 | 0 |
no
| null | null |
no dnr
| 32 | 70 | 12.199219 | 116 | 20 | 36.69531 | null | null | null | 0.899902 | 139 | null | 71 | 15 | null | null | 0 |
adl>=4 (>=5 if sur)
| 0 |
5,144 | 52.22998 | 0 |
male
| 0 | 23 | 650 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 14 |
>$50k
| 0 | 48,448 | 27,241.3438 | 21,755 | 20.333328 |
white
| 22.796875 | 34 | 0.848999 | 0.795898 | 2 | 0 | 0 |
no
| 0.5 | 0.5 |
no dnr
| 23 | 143 | 7.199219 | 55 | 22 | 36.29688 | 226.0625 | 3.799805 | 0.5 | 0.799927 | 144 | 7.399414 | 122 | 23 | null | 7 | 7 |
adl>=4 (>=5 if sur)
| 7 |
5,145 | 72.909 | 1 |
male
| 1 | 7 | 7 |
Coma
|
Coma
| 2 | 3 |
under $11k
| 100 | 53,008 | 30,680.5156 | 31,262 | 34.5 |
white
| 27.699219 | 63 | 0.028 | 0.012999 | 11 | 1 | 0 |
no
| 0.05 | 0.05 |
dnr after sadm
| 4 | 117 | 2.399902 | 165 | 53 | 39.69531 | 132.5 | 3.099609 | 0.5 | 1.199951 | 133 | 7.359375 | 157 | 10 | 4,550 | null | 1 |
<2 mo. follow-up
| 1 |
5,146 | 72.96899 | 0 |
male
| 0 | 15 | 650 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | 14 |
$11-$25k
| 0 | 28,292 | 17,936.1094 | 17,885 | 9 |
white
| 25.5 | 33 | 0.725952 | 0.640991 | 3 | 1 | 0 |
no
| 0.6 | 0.6 |
no dnr
| 15 | 105 | 17.097656 | 120 | 30 | 39.19531 | 192.5 | 2.399902 | 2.399902 | 0.5 | 137 | 7.399414 | 97 | 7 | 6,869 | null | 1 |
no(M2 and SIP pres)
| 1 |
5,147 | 65.03796 | 1 |
male
| 1 | 17 | 17 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | 11 |
$11-$25k
| 0 | 68,227 | 38,085.5312 | 41,467 | 35 |
white
| 24.796875 | 54 | 0.795898 | 0.727905 | 1 | 0 | 0 |
no
| 0.9 | 0.85 |
dnr after sadm
| 15 | 69 | 0.699951 | 108 | 24 | 38.39844 | null | null | null | 0.5 | 142 | null | 70 | 4 | null | null | 1 |
<2 mo. follow-up
| 1 |
5,148 | 53.36899 | 0 |
female
| 0 | 26 | 649 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 12 | null | 0 | 74,535 | 42,580.4375 | 41,409 | 25.25 |
black
| 29.699219 | 43 | 0.761963 | 0.685913 | 1 | 1 | 0 |
no
| 0.9 | 0.9 |
no dnr
| 26 | 68 | 7 | 65 | 24 | 36.39844 | null | null | 0.5 | 0.799927 | 136 | null | 124 | 13 | 1,550 | null | null |
no(M2 and SIP pres)
| 2.134766 |
5,149 | 70.935 | 0 |
female
| 0 | 9 | 649 |
COPD
|
COPD/CHF/Cirrhosis
| 1 | 15 |
>$50k
| 9 | 9,011 | 5,791.9414 | 6,667 | 7.5 |
white
| 19.699219 | 30 | 0.819946 | 0.706909 | 1 | 0 | 0 |
no
| 0.7 | 0.5 |
dnr after sadm
| 4 | 112 | 23.796875 | 120 | 12 | 38.5 | 283.3125 | 2.599609 | 1.599854 | 3 | 145 | 7.259766 | 82 | 58 | 1,490 | 5 | 5 |
no(M2 and SIP pres)
| 5 |
5,150 | 74.86395 | 1 |
female
| 1 | 41 | 41 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | 14 |
$25-$50k
| 0 | 293,806 | 168,017 | 171,702 | 36.25 |
white
| 26.898438 | 44 | 0.542969 | 0.428955 | 42 | 0 | 0 |
yes
| 0 | 0 |
dnr after sadm
| 41 | 42 | 16.898438 | 145 | 45 | 38.59375 | 210 | null | 0.399963 | 7.5 | 139 | 7.419922 | 507 | 101 | 15 | null | 6 |
<2 mo. follow-up
| 6 |
5,151 | 71.64099 | 1 |
male
| 0 | 6 | 52 |
Coma
|
Coma
| 1 | 12 |
under $11k
| 100 | 6,228 | 4,059.707 | 4,164 | 9 |
white
| 20.199219 | 28 | 0.246979 | 0.181 | 1 | 0 | 1 |
no
| 0.7 | 0.5 |
dnr after sadm
| 1 | 57 | 14.099609 | 115 | 10 | 39.5 | 118.32812 | 2.299805 | 0.699951 | 0.699951 | 141 | 7.439453 | 281 | 20 | 3,545 | null | 7 |
<2 mo. follow-up
| 7 |
5,152 | 29.65599 | 1 |
male
| 1 | 17 | 17 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 17 |
$11-$25k
| 0 | 281,407 | 160,268.5 | 143,505 | 37.666657 |
black
| 37.59375 | 64 | 0.619995 | 0.515991 | 40 | 0 | 0 |
no
| 0.2 | 0.2 |
dnr after sadm
| 16 | 68 | 16.398438 | 105 | 36 | 38.69531 | 110 | null | 0.5 | 0.799927 | 146 | 7.5 | 243 | 18 | 3,480 | null | 0 |
<2 mo. follow-up
| 0 |
5,153 | 51.73398 | 1 |
female
| 1 | 4 | 4 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 12 |
$25-$50k
| 100 | 24,569 | 14,623.6016 | 15,029 | 52 |
white
| 43.296875 | 105 | 0.035995 | 0.009998 | 1 | 0 | 0 |
no
| 0.5 | 0.4 |
dnr after sadm
| 2 | 58 | 9.5 | 115 | 30 | 38.29688 | 202.84375 | 2.5 | 0.5 | 0.899902 | 149 | 7.399414 | 137 | 25 | 2,370 | null | 0 |
<2 mo. follow-up
| 0 |
5,154 | 56.29797 | 0 |
male
| 0 | 64 | 646 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 12 | null | 0 | 227,291 | 151,162.875 | 154,709 | 46 |
white
| 41.695313 | 47 | 0.465942 | 0.346985 | 1 | 1 | 0 |
no
| 0.7 | 0.65 |
no dnr
| 64 | 101 | 6.799805 | 80 | 16 | 37.79688 | null | 3.899902 | 0.199982 | 1.099854 | 142 | null | 175 | 11 | null | null | 1 |
SIP>=30
| 1 |
5,155 | 49.26199 | 1 |
male
| 0 | 13 | 175 |
Cirrhosis
|
COPD/CHF/Cirrhosis
| 4 | 10 |
under $11k
| 0 | 15,670 | 10,045.3906 | 13,425 | 5 |
white
| 21.097656 | 48 | 0.830933 | 0.723999 | 1 | 1 | 0 |
no
| 0.95 | 0.9 |
no dnr
| 13 | 62 | 15.599609 | 35 | 33 | 35 | 190 | 2.599609 | null | 2.699707 | 138 | 7.369141 | 224 | 134 | 240 | 5 | 3 |
SIP>=30
| 3 |
5,156 | 61.46698 | 1 |
male
| 1 | 9 | 9 |
Lung Cancer
|
Cancer
| 2 | null | null | 0 | 13,209 | 7,907.5664 | 8,379 | 7 |
white
| 12.599609 | 12 | 0.791992 | 0.559937 | 1 | 0 | 0 |
metastatic
| 0.8 | 0.5 |
dnr after sadm
| 9 | 75 | 6.799805 | 67 | 20 | 36.19531 | null | 3.599609 | 0.399963 | 1 | 140 | null | 98 | 13 | 5,700 | 0 | 0 |
<2 mo. follow-up
| 0 |
5,157 | 92.73096 | 1 |
female
| 0 | 32 | 461 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | null |
$11-$25k
| 26 | 91,653 | 56,649.7812 | 61,899 | 20 |
black
| 22.199219 | 23 | 0.438965 | 0.31897 | 19 | 0 | 0 |
yes
| null | null |
dnr after sadm
| 19 | 65 | 10.298828 | 115 | 27 | 39.09375 | 146 | 2.799805 | 0.199982 | 0.399963 | 137 | 7.439453 | 139 | 11 | 2,174 | null | 0 |
adl>=4 (>=5 if sur)
| 0 |
5,158 | 60.63797 | 1 |
female
| 1 | 26 | 26 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 12 |
under $11k
| 0 | 145,919 | null | null | 32.25 |
white
| 16.796875 | 23 | 0.895996 | 0.858887 | 1 | 0 | 0 |
no
| 0.9 | 0.85 |
dnr after sadm
| 20 | 142 | 10.699219 | 72 | 26 | 38 | 246.65625 | null | null | 10.599609 | 136 | 7.429688 | 84 | 52 | 615 | 0 | 1 |
<2 mo. follow-up
| 1 |
5,159 | 56.59399 | 1 |
female
| 0 | 9 | 128 |
MOSF w/Malig
|
ARF/MOSF
| 2 | 16 | null | 0 | 21,295 | 12,869.1562 | 13,625 | 16 |
black
| 31.199219 | 47 | 0.428955 | 0.309998 | 2 | 0 | 0 |
metastatic
| null | null |
no dnr
| 9 | 68 | 9.398438 | 102 | 16 | 36.39844 | null | 3.399902 | 0.399963 | 0.5 | 141 | null | 88 | 5 | 7,455 | 1 | 0 |
adl>=4 (>=5 if sur)
| 0 |
5,160 | 63.02298 | 0 |
female
| 0 | 16 | 643 |
CHF
|
COPD/CHF/Cirrhosis
| 3 | 13 |
$25-$50k
| 0 | 21,498 | 13,531.0625 | 12,646 | 20.333328 |
white
| 17.398438 | 27 | 0.890991 | 0.816895 | 1 | 0 | 0 |
no
| null | null |
no dnr
| 16 | 68 | 10 | 110 | 29 | 37.79688 | 270 | 2.299805 | 0.399963 | 1.599854 | 154 | 7.339844 | 119 | 38 | 2,795 | 0 | 0 |
no(M2 and SIP pres)
| 0 |
5,161 | 60.90097 | 1 |
female
| 1 | 19 | 19 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | 7 | null | 9 | 99,519 | null | null | 39 |
white
| 44.09375 | 82 | 0.204987 | 0.110992 | 2 | 0 | 0 |
yes
| 0.5 | 0.25 |
dnr after sadm
| 12 | 62 | 2.799805 | 175 | 20 | 37.89844 | 133.3125 | 2.599609 | 1.199951 | 2.199707 | 140 | 7.40918 | 185 | 54 | 4,155 | null | 6 |
<2 mo. follow-up
| 6 |
5,162 | 63.92099 | 1 |
female
| 0 | 3 | 353 |
COPD
|
COPD/CHF/Cirrhosis
| 3 | 8 | null | 0 | 3,315 | 2,266.6445 | 2,414 | 12 |
white
| 22.199219 | 37 | 0.807983 | 0.689941 | 1 | 0 | 0 |
yes
| 0.5 | 0.25 |
no dnr
| 3 | 65 | 3.399902 | 105 | 36 | 37.89844 | 126.51562 | null | 1 | 2.299805 | 132 | 7.369141 | 107 | 37 | 2,325 | null | null |
no(M2 and SIP pres)
| 2.53418 |
5,163 | 55.85999 | 0 |
female
| 0 | 25 | 642 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 12 |
under $11k
| 37 | 79,183 | null | null | 30.25 |
white
| 23.097656 | 53 | 0.753906 | 0.675903 | 1 | 0 | 0 |
no
| 0.8 | 0.75 |
no dnr
| 25 | 70 | 6.599609 | 65 | 30 | 35 | 223.3125 | 2.899902 | null | 1.399902 | 136 | 7.40918 | 92 | 34 | 2,530 | null | 0 |
no(M2 and SIP pres)
| 0 |
5,164 | 54.021 | 1 |
male
| 0 | 3 | 536 |
Lung Cancer
|
Cancer
| 2 | 11 |
$11-$25k
| 0 | null | 1,357.7764 | 1,846 | 5 |
white
| 30.796875 | 17 | 0.386963 | 0.094986 | 1 | 0 | 0 |
metastatic
| 0.8 | 0.5 |
no dnr
| 3 | 78 | 2.5 | 105 | 20 | 36 | 214.28125 | 1.599854 | 1.899902 | 1.399902 | 142 | 7.40918 | 132 | 40 | 200 | 2 | 2 |
no(M2 and SIP pres)
| 2 |
5,165 | 64.49799 | 0 |
male
| 0 | 49 | 641 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 12 |
$11-$25k
| 41 | 148,554 | 83,934.25 | 96,493 | 30.25 |
white
| 32.898438 | 43 | 0.392944 | 0.273987 | 4 | 0 | 0 |
no
| 0.8 | 0.75 |
no dnr
| 49 | 72 | 18.398438 | 85 | 19 | 36.39844 | 180 | 2.599609 | null | 1.5 | 134 | 7.429688 | 166 | 39 | 5,778 | null | 0 |
no(M2 and SIP pres)
| 0 |
5,166 | 60.86798 | 0 |
male
| 0 | 6 | 641 |
CHF
|
COPD/CHF/Cirrhosis
| 2 | 4 |
under $11k
| 0 | 9,822 | 6,247.3242 | 6,229 | 23 |
white
| 17.097656 | 18 | 0.897949 | 0.828979 | 1 | 0 | 0 |
no
| 0.9 | 0.6 |
no dnr
| 6 | 100 | 20.296875 | 84 | 20 | 37 | 498 | null | null | 0.899902 | 143 | 7.279297 | 102 | 26 | 2,660 | 2 | null |
adl>=4 (>=5 if sur)
| 1.838867 |
5,167 | 55.17899 | 0 |
male
| 0 | 106 | 640 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | 12 | null | 26 | 573,218 | 320,278 | 339,372 | 37.75 |
black
| 25.898438 | 34 | 0.641968 | 0.540894 | 57 | 0 | 0 |
no
| null | null |
no dnr
| 106 | 35 | 13.398438 | 145 | 34 | 39 | 237.125 | null | null | 1.699951 | 146 | 7.389648 | 114 | 39 | 845 | null | 0 | null | 0 |
5,168 | 47.84399 | 1 |
female
| 1 | 4 | 4 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 10 | null | 100 | 34,109 | null | null | 33 |
other
| 21.398438 | 22 | 0.55188 | 0.438965 | 3 | 1 | 0 |
no
| 0 | 0 |
dnr after sadm
| 2 | 117 | 10 | 75 | 40 | 38.39844 | 260 | null | 11.599609 | 2.599609 | 141 | 7.479492 | 250 | 63 | 1,950 | null | 0 |
<2 mo. follow-up
| 0 |
5,169 | 53.51099 | 1 |
female
| 0 | 18 | 88 |
Lung Cancer
|
Cancer
| 1 | 20 |
>$50k
| 0 | 36,304 | 21,369.9688 | 19,303 | 11.666664 |
white
| 15 | 13 | 0.767944 | 0.519897 | 1 | 0 | 0 |
metastatic
| 0.8 | 0.6 |
no dnr
| 18 | 115 | 15.898438 | 125 | 45 | 38.5 | 233.3125 | 2.599609 | null | 0.699951 | 137 | 7.439453 | 132 | 6 | 3,555 | 2 | null |
adl>=4 (>=5 if sur)
| 1.838867 |
5,170 | 78.64795 | 0 |
female
| 0 | 6 | 637 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | 8 | null | 0 | 43,537 | 25,966.8438 | 29,665 | 11 |
white
| 14.699219 | 16 | 0.8479 | 0.795898 | 6 | 1 | 0 |
no
| 0.95 | 0.9 |
no dnr
| 6 | 38 | 3.599609 | 130 | 8 | 34.79688 | 152 | 2 | 0.699951 | 2.099609 | 130 | 7.429688 | 33 | 24 | 3,280 | 0 | 0 |
no(M2 and SIP pres)
| 0 |
5,171 | 41.11697 | 0 |
female
| 0 | 27 | 637 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | 10 |
under $11k
| 9 | 113,278 | 66,799.8125 | 68,660 | 27 |
black
| 16.5 | 24 | 0.890991 | 0.851929 | 16 | 0 | 0 |
no
| 0.5 | 0.5 |
no dnr
| 27 | 126 | 4.199219 | 70 | 26 | 38.09375 | 371.375 | null | null | 1.299805 | 137 | 7.369141 | 87 | 7 | 2,800 | null | 1 |
adl>=4 (>=5 if sur)
| 1 |
5,172 | 79.37897 | 0 |
male
| 0 | 17 | 637 |
Coma
|
Coma
| 0 | null | null | 41 | 169,122 | 99,286.75 | 100,516 | 33.666657 |
white
| 16.597656 | 28 | 0.440979 | 0.366943 | 41 | 0 | 0 |
no
| null | null |
no dnr
| 17 | 136 | 7.099609 | 45 | 12 | 38 | 286.625 | 2.799805 | null | 2 | 137 | 7.389648 | 288 | 31 | 1,715 | null | null | null | 1.862061 |
5,173 | 55.61899 | 0 |
male
| 0 | 17 | 637 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4 | 8 | null | 41 | 32,806 | null | null | 12.666664 |
white
| 17.296875 | 14 | 0.762939 | 0.68689 | 3 | 1 | 0 |
yes
| 0.75 | 0.6 |
no dnr
| 17 | 120 | 5.299805 | 60 | 26 | 36.19531 | 276 | null | 0.399963 | 1 | 144 | 7.379883 | 194 | 18 | 2,250 | null | 1 |
no(M2 and SIP pres)
| 1 |
5,174 | 30.40099 | 0 |
female
| 0 | 113 | 635 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 12 |
$11-$25k
| 0 | 461,600 | null | null | 43.25 |
black
| 30.097656 | 40 | 0.834961 | 0.778931 | 1 | 0 | 0 |
no
| 0.6 | 0.6 |
no dnr
| 113 | 132 | 4.5 | 68 | 24 | 38.09375 | 219.03125 | null | 0.599976 | 1.799805 | 139 | 7.369141 | 229 | 33 | 4,150 | null | 1 |
adl>=4 (>=5 if sur)
| 1 |
5,175 | 64.797 | 0 |
male
| 0 | 63 | 635 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | null |
$25-$50k
| 0 | 286,996 | 162,759.125 | 158,849 | 43.5 |
white
| 26 | 44 | 0.706909 | 0.61792 | 16 | 0 | 0 |
no
| 0.8 | 0.8 |
no dnr
| 63 | 72 | 17.199219 | 125 | 25 | 36.5 | 330 | 1.899902 | 2.899902 | 1.799805 | 149 | 7.419922 | 108 | 30 | 1,550 | null | 0 |
SIP>=30
| 0 |
5,176 | 86.91595 | 1 |
female
| 0 | 16 | 53 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | null |
under $11k
| 9 | 96,288 | 59,030.1875 | 58,776 | 18.333328 |
white
| 23.296875 | 30 | 0.599976 | 0.492981 | 36 | 0 | 0 |
no
| null | null |
dnr after sadm
| 3 | 68 | 22.597656 | 95 | 14 | 36.09375 | 116.65625 | null | 1.5 | 5.399414 | 130 | 7.429688 | 156 | 75 | 43 | null | 0 |
<2 mo. follow-up
| 0 |
5,177 | 80.323 | 0 |
male
| 0 | 9 | 634 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 14 | null | 0 | 24,828 | null | null | 22 |
white
| 20.5 | 36 | 0.72998 | 0.646973 | 3 | 0 | 0 |
yes
| 1 | 0.6 |
no dnr
| 9 | 103 | 3.599609 | 75 | 20 | 36.79688 | null | 2.299805 | 1.399902 | 1.599854 | 137 | null | 109 | 4 | null | null | 0 | null | 0 |
5,178 | 27.26099 | 0 |
male
| 0 | 9 | 633 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 12 |
under $11k
| 0 | 22,451 | null | null | 19 |
black
| 31.5 | 59 | 0.827881 | 0.768921 | 1 | 0 | 0 |
no
| 0.9 | 0.85 |
no dnr
| 9 | 118 | 15.298828 | 55 | 34 | 38.79688 | 220 | 2.399902 | 4.099609 | 0.799927 | 152 | 7.389648 | 102 | 13 | 4,770 | 0 | 0 |
no(M2 and SIP pres)
| 0 |
5,179 | 46.47998 | 1 |
male
| 1 | 7 | 7 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4 | 9 |
under $11k
| 0 | 36,739 | null | null | 38 |
black
| 35.59375 | 52 | 0.680908 | 0.586914 | 1 | 0 | 0 |
no
| 0.5 | 0.3 |
dnr after sadm
| 5 | 77 | 8.298828 | 60 | 26 | 37.59375 | 257.125 | null | 1.099854 | 1.199951 | 141 | 7.519531 | 111 | 10 | 2,025 | null | 0 |
<2 mo. follow-up
| 0 |
5,180 | 65.94397 | 1 |
female
| 1 | 18 | 18 |
Cirrhosis
|
COPD/CHF/Cirrhosis
| 4 | 4 |
under $11k
| 100 | 26,626 | null | null | 16 |
black
| 25.097656 | 49 | 0.167999 | 0.043999 | 1 | 1 | 0 |
no
| 0.2 | 0.05 |
dnr after sadm
| 18 | 67 | 10.298828 | 55 | 35 | 38.59375 | 212.5 | null | 5 | 3.699707 | 136 | 7.469727 | 286 | 82 | 4,600 | null | 4 |
<2 mo. follow-up
| 4 |
5,181 | 70.75397 | 0 |
female
| 0 | 13 | 631 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 9 |
$11-$25k
| 9 | 27,012 | 16,491.5312 | 17,150 | 22.5 |
white
| 19.597656 | 31 | 0.813965 | 0.751953 | 2 | 1 | 0 |
no
| 0.6 | 0.4 |
no dnr
| 13 | 60 | 9.798828 | 55 | 24 | 35.79688 | 309.5 | 4 | 1.099854 | 1.899902 | 150 | 7.449219 | 70 | 53 | 1,475 | 0 | 0 |
no(M2 and SIP pres)
| 0 |
5,182 | 73.10596 | 0 |
female
| 0 | 22 | 632 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 7 |
$25-$50k
| 44 | 174,244 | null | null | 36 |
white
| 35.796875 | 63 | 0.173981 | 0.088989 | 22 | 0 | 0 |
no
| 0.5 | 0.3 |
no dnr
| 22 | 103 | 14 | 75 | 24 | 38.79688 | 281 | null | 0.699951 | 1.199951 | 137 | 7.439453 | 88 | 13 | 1,240 | null | 6 |
Coma or Intub
| 6 |
5,183 | 56.89499 | 0 |
male
| 0 | 8 | 632 |
CHF
|
COPD/CHF/Cirrhosis
| 3 | null | null | 0 | 18,632 | null | null | 20 |
black
| 23.097656 | 45 | 0.852905 | 0.756958 | 1 | 0 | 0 |
no
| null | null |
no dnr
| 8 | 62 | 26.898438 | 75 | 36 | 35.79688 | 115.70312 | 2.299805 | 0.899902 | 5 | 137 | 7.329102 | 148 | 69 | 66 | null | null | null | 2.893066 |
5,184 | 52.79099 | 0 |
male
| 0 | 8 | 632 |
CHF
|
COPD/CHF/Cirrhosis
| 2 | 12 |
$11-$25k
| 0 | 12,395 | 4,226.0586 | 4,189 | 7.5 |
white
| 16.097656 | 9 | 0.919922 | 0.86499 | 1 | 0 | 0 |
no
| null | null |
no dnr
| 8 | 120 | 14.5 | 105 | 11 | 38.5 | 316.625 | null | 2.5 | 2.099609 | 148 | 7.419922 | 60 | 34 | 2,510 | 0 | 0 |
no(M2 and SIP pres)
| 0 |
5,185 | 75.87994 | 1 |
female
| 0 | 9 | 225 |
CHF
|
COPD/CHF/Cirrhosis
| 4 | 11 |
under $11k
| 9 | 17,026 | null | null | 18 |
white
| 29.097656 | 40 | 0.637939 | 0.45697 | 1 | 0 | 0 |
no
| 0.4 | 0.3 |
dnr after sadm
| 2 | 125 | 25.699219 | 125 | 32 | 37.69531 | 246.65625 | null | null | 2.599609 | 141 | 7.399414 | 249 | 70 | 1,155 | 0 | 0 |
no(M2 and SIP pres)
| 0 |
5,186 | 60.66498 | 0 |
male
| 0 | 7 | 631 |
CHF
|
COPD/CHF/Cirrhosis
| 3 | 7 |
under $11k
| 0 | 14,779 | null | null | 19.5 |
white
| 20.398438 | 43 | 0.869995 | 0.783936 | 1 | 1 | 0 |
no
| 0.8 | 0.7 |
no dnr
| 7 | 117 | 12.398438 | 112 | 24 | 38.19531 | 210.1875 | 1.399902 | 4.899414 | 1.099854 | 132 | 7.299805 | 174 | 19 | 3,575 | 3 | 1 |
no(M2 and SIP pres)
| 1 |
5,187 | 69.64496 | 1 |
female
| 0 | 14 | 49 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 13 |
>$50k
| 0 | 79,048 | 46,799.625 | 45,539 | 23 |
white
| 24.597656 | 42 | 0.704956 | 0.615967 | 22 | 0 | 0 |
no
| 0.1 | 0.5 |
dnr after sadm
| 3 | 160 | 43.195313 | 125 | 28 | 37.69531 | 280 | 2.199707 | 1.099854 | 2.5 | 151 | 7.369141 | 202 | 59 | 2,110 | null | 0 |
<2 mo. follow-up
| 0 |
5,188 | 53.06998 | 1 |
male
| 0 | 4 | 202 |
Lung Cancer
|
Cancer
| 1 | 12 |
$11-$25k
| 0 | 6,650 | null | null | 9 |
white
| 14.398438 | 9 | 0.779907 | 0.539917 | 1 | 0 | 0 |
metastatic
| 0.8 | 0.5 |
no dnr
| 4 | 103 | 5.5 | 80 | 20 | 36.19531 | null | null | null | 1.5 | 138 | null | 148 | 17 | null | null | 0 |
no(M2 and SIP pres)
| 0 |
5,189 | 82.54297 | 1 |
male
| 0 | 14 | 15 |
COPD
|
COPD/CHF/Cirrhosis
| 2 | 13 |
$11-$25k
| 0 | 14,698 | null | null | 9.333328 |
white
| 21.597656 | 8 | 0.611938 | 0.424988 | 1 | 0 | 0 |
metastatic
| 0.5 | 0.25 |
dnr after sadm
| 5 | 58 | 16.796875 | 65 | 8 | 38.29688 | 172 | null | null | 1.5 | 144 | 7.349609 | 292 | 32 | 7,315 | 2 | 1 |
<2 mo. follow-up
| 1 |
5,190 | 68.383 | 0 |
male
| 0 | 10 | 628 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3 | 16 | null | 0 | 35,772 | null | null | 25.5 |
white
| 23.597656 | 38 | 0.787964 | 0.717896 | 2 | 1 | 0 |
no
| 0.8 | 0.7 |
no dnr
| 10 | 93 | 8.898438 | 65 | 28 | 39.5 | 185 | null | null | 0.699951 | 137 | 7.369141 | 149 | 14 | 1,595 | 0 | 0 |
no(M2 and SIP pres)
| 0 |
5,191 | 85.74396 | 1 |
female
| 0 | 7 | 263 |
COPD
|
COPD/CHF/Cirrhosis
| 2 | null | null | 0 | 5,616 | 3,942.7949 | 4,634 | 4 |
white
| 17.898438 | 22 | 0.777954 | 0.645996 | 1 | 1 | 0 |
no
| 0.8 | 0.7 |
no dnr
| 7 | 122 | 13.898438 | 120 | 29 | 36.59375 | 250 | 2.099609 | 0.199982 | 0.899902 | 133 | 7.359375 | 81 | 8 | 3,965 | 3 | null | null | 2.510742 |
5,192 | 68.02496 | 1 |
male
| 0 | 5 | 154 |
CHF
|
COPD/CHF/Cirrhosis
| 2 | 5 |
under $11k
| 9 | 3,742 | 2,707.2363 | 2,761 | 8 |
black
| 31.5 | 45 | 0.630981 | 0.447998 | 1 | 0 | 0 |
no
| null | null |
no dnr
| 5 | 52 | 13.898438 | 60 | 11 | 39.5 | 205.6875 | 2.799805 | 0.299988 | 2.599609 | 142 | 7.239258 | 527 | 44 | 360 | null | 2 |
adl>=4 (>=5 if sur)
| 2 |
5,193 | 49.93298 | 1 |
male
| 0 | 18 | 50 |
Colon Cancer
|
Cancer
| 1 | 12 |
>$50k
| 0 | 27,935 | null | null | 17 |
white
| 19.898438 | 25 | 0.805908 | 0.585938 | 1 | 0 | 0 |
metastatic
| null | null |
no dnr
| 18 | 70 | 5.299805 | 105 | 33 | 38.19531 | 205 | null | null | 1.199951 | 127 | 7.379883 | 234 | 21 | 960 | null | 0 |
<2 mo. follow-up
| 0 |
5,194 | 20.48199 | 0 |
male
| 0 | 35 | 627 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 14 | null | 0 | 200,937 | 114,746.375 | 112,610 | 36.75 |
white
| 28 | 64 | 0.85498 | 0.803955 | 6 | 0 | 0 |
no
| 0.6 | 0.6 |
no dnr
| 35 | 58 | 13.699219 | 115 | 38 | 38.19531 | 213.3125 | null | 0.799927 | 1.399902 | 148 | 7.339844 | 100 | 55 | 1,375 | 0 | null |
no(M2 and SIP pres)
| 0.494751 |
5,195 | 87.92596 | 1 |
female
| 0 | 49 | 465 |
COPD
|
COPD/CHF/Cirrhosis
| 3 | 15 |
$11-$25k
| 9 | 50,071 | 33,320.0312 | 35,008 | 16.75 |
white
| 20.898438 | 24 | 0.67395 | 0.50293 | 1 | 0 | 1 |
no
| null | null |
dnr after sadm
| 3 | 120 | 16.199219 | 125 | 42 | 37.69531 | 170 | 2.399902 | 0.5 | 0.5 | 132 | 7.449219 | 113 | 13 | 5,325 | null | 1 |
adl>=4 (>=5 if sur)
| 1 |
5,196 | 34.995 | 0 |
male
| 0 | 10 | 626 |
MOSF w/Malig
|
ARF/MOSF
| 1 | 14 |
>$50k
| 0 | 19,106 | 11,641.5312 | 12,083 | 11 |
white
| 23.597656 | 42 | 0.665894 | 0.569946 | 2 | 0 | 0 |
metastatic
| 0.95 | 0.85 |
no dnr
| 10 | 101 | 26.796875 | 136 | 24 | 36.69531 | 348 | 3.799805 | 0.299988 | 0.899902 | 140 | 7.389648 | 220 | 22 | null | 0 | 0 |
no(M2 and SIP pres)
| 0 |
5,197 | 76.047 | 0 |
male
| 0 | 6 | 626 |
COPD
|
COPD/CHF/Cirrhosis
| 4 | 16 |
>$50k
| 0 | 5,420 | null | null | 9 |
white
| 14.798828 | 20 | 0.868896 | 0.782959 | 1 | 0 | 0 |
no
| null | null |
no dnr
| 6 | 52 | 21.597656 | 70 | 12 | 38.09375 | 134 | 2.599609 | 0.799927 | 1.299805 | 149 | 7.379883 | 147 | 46 | 910 | 0 | null |
no(M2 and SIP pres)
| 0.494751 |
5,198 | 46.99197 | 1 |
female
| 1 | 14 | 14 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | null | null | 0 | 109,299 | 55,014.5938 | 59,859 | 38.666657 |
other
| 22.199219 | 19 | 0.837891 | 0.782959 | 12 | 0 | 0 |
no
| null | null |
dnr before sadm
| -2 | 145 | 20.296875 | 56 | 22 | 36 | null | null | 1 | 1.299805 | 143 | null | 121 | 32 | 1,425 | null | 7 |
<2 mo. follow-up
| 7 |
5,199 | 40.47897 | 0 |
female
| 0 | 7 | 624 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 16 |
$11-$25k
| 0 | 9,844 | 6,419.6797 | 6,699 | 6 |
black
| 14 | 18 | 0.942993 | 0.921997 | 1 | 0 | 0 |
no
| null | null |
no dnr
| 7 | 115 | 27.796875 | 115 | 20 | 35.69531 | 176.65625 | null | 3.099609 | 3 | 129 | 7.449219 | 380 | 70 | 975 | 0 | 0 |
no(M2 and SIP pres)
| 0 |
5,200 | 62.07797 | 0 |
male
| 0 | 4 | 624 |
COPD
|
COPD/CHF/Cirrhosis
| 1 | 6 |
under $11k
| 0 | 6,699 | 4,312.0977 | 4,687 | 15 |
black
| 19.097656 | 31 | 0.884888 | 0.807983 | 1 | 0 | 0 |
no
| null | null |
no dnr
| 4 | 58 | 31.398438 | 145 | 34 | 35.29688 | 91.42188 | null | null | 2.799805 | 150 | 7.429688 | 53 | 41 | 350 | 1 | null |
no(M2 and SIP pres)
| 1.166748 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.